Neimeth International Pharmaceuticals Plc

NGSE:NEIMETH Stock Report

Mkt Cap: ₦3.0b

Neimeth International Pharmaceuticals Financial Health

How is Neimeth International Pharmaceuticals's financial position?

Financial Health Score

2/6

Financial Health Score 2/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: NEIMETH's short term assets (NGN3.7B) exceed its short term liabilities (NGN3.6B).

Long Term Liabilities: NEIMETH's short term assets (NGN3.7B) exceed its long term liabilities (NGN2.1B).


Debt to Equity History and Analysis

Debt Level: NEIMETH's net debt to equity ratio (427.4%) is considered high.

Reducing Debt: NEIMETH's debt to equity ratio has increased from 119.2% to 477.4% over the past 5 years.

Debt Coverage: NEIMETH's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if NEIMETH's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies